Rapport Therapeutics, Inc. Common Stock (RAPP) Insider Trading
- $1,240,914.64
- $119,000.00
- July 15, 2025
- David Bredt
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| July 15, 2025 | Insider | 8,500 | $14.00 | Sell | $119,000.00 | |
| March 12, 2025 | Director | 6,000 | $10.21 | Buy | $61,260.00 | |
| March 12, 2025 | CFO | 9,900 | $10.10 | Buy | $99,990.00 | |
| July 1, 2024 | Director | 44,032 | $24.52 | Buy | $1,079,664.64 |
Insiders are both buying and selling Rapport Therapeutics, Inc. Common Stock stock.
The insider traders at Rapport Therapeutics, Inc. Common Stock are: David Bredt, James Healy, Troy A Ignelzi, and Wendy B Young
The most active insider trader at Rapport Therapeutics, Inc. Common Stock is David Bredt with 1 trades.
David Bredt has sold the most Rapport Therapeutics, Inc. Common Stock stock with a total value of $238,000.00.
James Healy has bought the most Rapport Therapeutics, Inc. Common Stock stock with a total value of $2,159,329.28.
The most recent insider trade for Rapport Therapeutics, Inc. Common Stock was on July 15, 2025.
The single biggest insider buy for Rapport Therapeutics, Inc. Common Stock was from James Healy with a total value of $1,079,664.64 on July 1, 2024.
The single biggest insider sell for Rapport Therapeutics, Inc. Common Stock was from David Bredt with a total value of $119,000.00 on July 15, 2025.